Medullary thyroid cancer: Are practice patterns in the united states discordant from american thyroid association guidelines?

Annals of Surgical Oncology

Volumn 17, Issue 6, 2010, Pages 1490-1498

  Panigrahi, Babita ^a   Roman, Sanziana A ^a   Sosa, Julie Ann ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL PRACTICE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRACTICE GUIDELINE; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; UNITED STATES;

ADULT; AGED; BENCHMARKING; CARCINOMA, MEDULLARY; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIETIES, MEDICAL; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; UNITED STATES;

EID: 77954817844     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1017-0     Document Type: Article

References (37)

1. American Cancer Society (2009). Cancer facts and figures. Available at: http://www.cancer.org. Accessed October 2009.
2. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer. 2000;88:1139-1148
3. Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006;107:2134-2142
4. You YN, Lakhani V, Wells SA Jr, Moley JF. Medullary thyroid cancer. Surg Oncol Clin N Am. 2006;15:639-660
5. Faik Erdogan M, Gursoy A, Erdogan G, Kamel N. Radioactive iodine treatment in medullary thyroid carcinoma. Nucl Med Commun. 2006;27:359-362
6. Schlumberger M, Abdelmoumene N, Delisle MJ, Couette JE. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC). Br J Cancer. 1995;71:363-365
7. Nocera M, Baudin E, Pellegriti G, et al. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. groupe d'etude des tumeurs a calcitonine (GETC). Br J Cancer. 2000;83:715-718
8. Schwartz DL, Rana V, Shaw S, et al. Postoperative radiotherapy for advanced medullary thyroid cancer-local disease control in the modern era. Head Neck. 2008;30:883-888
9. Weisz G, Cambrosio A, Keating P, et al. The emergence of clinical practice guidelines. Milbank Q. 2007;85:691-727.
10. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109-142
11. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19: 1167-1214
12. British Thyroid Association. Guidelines for the management of thyroid cancer. 2007. Available at: http://www.british-thyroidassociation. org/Guidelines/. Accessed August 2009.
13. Al-Rawi M, Wheeler MH. Medullary thyroid carcinoma-update and present management controversies. Ann R Coll Surg Engl. 2006;88:433-438
14. National Comprehensive Cancer Network. Clinical practice guidelines for medullary thyroid carcinoma. 2009. Available at: http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp. Accessed August 2009.
15. Gharib H, Papini E, Valcavi R, et al. American association of clinical endocrinologists and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2006;12:63-102.
16. American Head and Neck Society. Guidelines for medullary thyroid carcinoma. 1995. Available at: http://www.ahns.info/ clinicalresources/ guidelines.php. Accessed November 2009.
17. American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19:565-612.
18. Miyauchi A, Matsuzuka F, Hirai K, et al. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma. World J Surg. 2000;24:1367-1372
19. Miyauchi A, Matsuzuka F, Hirai K, et al. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations. World J Surg. 2002;26:1023-1028
20. Ito Y, Miyauchi A, Yabuta T, et al. Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution. World J Surg. 200;33:58-66.
21. National Cancer Institute D, Surveillance Research Program, Cancer Statistics Branch. Available at: http://seer.cancer.gov/ registries/. Accessed August 2009.
22. National Cancer Institute D, Surveillance Research Program, Cancer Statistics Branch. Available at: http://seer.cancer.gov/ about/. Accessed August 2009.
23. Wang TS, Roman SA, Cox H, Air M, Sosa JA. The management of thyroid nodules in patients with primary hyperparathyroidism. J Surg Res. 2009;154:317-323
24. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342(8883):1317-1322
25. Worrall G, Chaulk P, Freake D. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review. CMAJ. 1997;156:1705-1712
26. Famakinwa O, Roman SA, Wang TS, Sosa JA. ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States? Am J Surg. 2010;199:189-198
27. Ahern CH, Shen Y. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines. Cancer Epidemiol Biomarkers Prev. 2009;18: 718-725
28. US Preventive Services Task Force. Screening for breast cancer: US preventive services task force recommendation statement. Ann Intern Med. 2009;151:716-726
29. Fiscella K, Franks P, Gold MR, Clancy CM. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000;283:2579-2584
30. Sosa JA, Bowman HM, Tielsch JM, et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998;228:320-330
31. Sosa JA, Mehta PJ, Wang TS, Boudourakis L, Roman SA. A population-based study of outcomes from thyroidectomy in aging americans: at what cost? J Am Coll Surg. 2008;206:1097-1105
32. Sosa JA, Mehta PJ, Wang TS, Yeo HL, Roman SA. Racial disparities in clinical and economic outcomes from thyroidectomy. Ann Surg. 2007;246:1083-1091
33. Tehranifar P, Neugut AI, Phelan JC, et al. Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev. 2009;18:2701-2708
34. Lillie-Blanton M, Maleque S, Miller W. Reducing racial, ethnic, and socioeconomic disparities in health care: opportunities in national health reform. J Law Med Ethics. 2008;36:693, 702, 608.
35. Lundgren CI, Delbridge L, Learoyd D, Robinson B. Surgical approach to medullary thyroid cancer. Arq Bras Endocrinol Metab. 2007;51:818-824
36. Herbert MA, Prince SL, Williams JL, Magee MJ, Mack MJ. Are unaudited records from an outcomes registry database accurate? Ann Thorac Surg. 2004;77:1960, 4.
37. American Thyroid Association Surgery Working Group, American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society, Carty SE, Cooper DS, Doherty GM, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19:1153-1158